Halozyme Therapeutics Inc... (HALO)
NASDAQ: HALO
· Real-Time Price · USD
67.28
1.74 (2.65%)
At close: Aug 15, 2025, 3:59 PM
67.50
0.33%
After-hours: Aug 15, 2025, 07:58 PM EDT
Halozyme Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 165.16M | 118.09M | 137.01M | 137.01M | 93.25M | 76.82M | 85.39M | 81.84M | 74.75M | 39.62M | 57.7M | 61.63M | 22.68M | 60.11M | 66.77M | 216.59M | 91.46M | 27.89M |
Depreciation & Amortization | 20.5M | 20.45M | 20.41M | 20.36M | 20.36M | 20.21M | 20.69M | 23.08M | 20.63M | 20.46M | 7.11M | 29.2M | 12.55M | 778K | 773K | 751K | 735K | 738K |
Stock-Based Compensation | 12.16M | 10.67M | 11.46M | 12.58M | 9.47M | 9.87M | 9.66M | 9.37M | 9.62M | 7.97M | 7.22M | 6.8M | 5.63M | 4.74M | 5.13M | 5.4M | 5.37M | 4.92M |
Other Working Capital | n/a | 4.22M | 55.81M | 37.18M | -42.24M | 23.48M | -22.14M | -10.4M | 4.87M | -4.93M | 10.41M | -5.04M | 5.86M | -9.17M | -2.74M | -3.19M | 3.34M | -2.33M |
Other Non-Cash Items | -83.55M | 390K | -499K | -926K | 90.95M | 51.89M | 3.28M | -13.66M | -1.19M | 1.24M | 817K | 5.9M | 2.26M | 910K | 1.03M | 283K | 284K | 21.5M |
Deferred Income Tax | -7.09M | -2.86M | -15.29M | 292K | 14.24M | 1.29M | 9.42M | 9.7M | 11.51M | 3.87M | 14.68M | 25.7M | -13.3M | 12.93M | -12.95M | -141.91M | 594K | 351K |
Change in Working Capital | -7.47M | 7.47M | 25.37M | -53.94M | -82.26M | 21.55M | -26.1M | 22.09M | -48.48M | 13.81M | -5.08M | -59.6M | 10.39M | -31.67M | 21.77M | 40.63M | -61.55M | 2.89M |
Operating Cash Flow | 99.71M | 154.22M | 178.47M | 115.38M | 55.79M | 129.43M | 102.35M | 132.41M | 66.84M | 86.96M | 82.45M | 69.64M | 40.23M | 47.8M | 82.52M | 121.74M | 36.89M | 58.3M |
Capital Expenditures | -1.56M | -950K | -3.05M | -1.52M | -2.58M | -3.54M | -2.6M | -2.94M | 1.62M | -11.38M | -2.34M | -1.01M | -968K | -490K | -158K | -496K | -533K | -270K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | 5.7M | 80.51M | n/a | 48.78M | 9.98M | n/a | -999.12M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -102.76M | -139.64M | -51.44M | -303.97M | -93.42M | -198.76M | -21.29M | -161.7M | n/a | -109.92M | -29.52M | n/a | -40.87M | -184.81M | -369.16M | -41.43M | -120.95M | -120.98M |
Sales Maturities Of Investments | 189.11M | 50.17M | 83.98M | 138.01M | 53.96M | 119.63M | 15.6M | 81.19M | 53.37M | 61.13M | 20.13M | n/a | 590M | 136M | 69.85M | 24.97M | 76.86M | 76M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | -39.46M | -79.14M | -5.7M | -80.51M | 53.37M | -48.78M | 9.98M | n/a | 16.02M | -48.81M | -299.31M | -16.46M | -44.08M | -44.98M |
Investing Cash Flow | 84.79M | -90.42M | 29.48M | -167.48M | -42.04M | -82.68M | -8.29M | -83.45M | 54.99M | -60.16M | -1.75M | -1.01M | -434.95M | -49.3M | -299.47M | -16.95M | -44.62M | -45.25M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -13.48M | n/a | 184.97M | 364M | n/a | n/a | n/a | n/a | 415.81M |
Common Stock Repurchased | -303.49M | n/a | -250M | n/a | n/a | -489K | -252.3M | n/a | 1.05M | -150.08M | -1K | -200M | n/a | n/a | -160.32M | -64.72M | -48.84M | -76.18M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | -13.48M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 3.32M | -3.32M | 3.58M | n/a | 9.48M | -489K | 2.38M | 4.1M | 2.45M | -1.05M | 6.33M | 2.64M | 3.82M | 624K | 4.31M | 4.65M | 3.48M | -329K |
Financial Cash Flow | -298.97M | -3.32M | -246.41M | 18.56M | 9.48M | -489K | -249.92M | 4.1M | 2.45M | -164.61M | 6.33M | -12.4M | 367.82M | 624K | -156.01M | -60.07M | -44.76M | 338.7M |
Net Cash Flow | -114.47M | 60.48M | -38.47M | -33.55M | 23.24M | 46.26M | -155.86M | 53.06M | 124.28M | -137.81M | 87.04M | 56.23M | -26.9M | -884K | -372.96M | 44.72M | -52.48M | 351.75M |
Free Cash Flow | 98.15M | 153.27M | 175.41M | 113.86M | 53.21M | 125.88M | 99.76M | 129.47M | 68.47M | 75.59M | 80.11M | 68.63M | 39.26M | 47.31M | 82.36M | 121.24M | 36.36M | 58.03M |